600613.SH
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 6.32
+0.64%Oct 30, 2026, 09:14 UTC
Shenqi Pharmaceutical reported main business revenue of RMB 1.249 billion for January–September 2026, down 10.62% year over year, with a gross margin of 44.37%, down 2.69 percentage points.
Source:Aug 28, 2026, 08:46 UTC
Shenqi Pharmaceutical released its 2026 semi-annual report, reporting net profit of 21.9656 million yuan, down 33.05% year-on-year.
Source: